4
Participants
Start Date
August 8, 2022
Primary Completion Date
March 31, 2024
Study Completion Date
June 30, 2025
TR004 (Treg immunotherapy)
Administered Intravenously (IV)
RECRUITING
Guy's Hospital - Guy's and St Thomas' NHS Foundation Trust, London
Collaborators (1)
Guy's and St Thomas' NHS Foundation Trust
OTHER
Medical Research Council
OTHER_GOV
St. George's Hospital, London
OTHER
Miltenyi biotech
UNKNOWN
King's College London
OTHER